Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD study.
| Author | |
|---|---|
| Abstract |
:
The goal of this study was to identify serum markers that are modulated by treatment with golimumab with or without methotrexate (MTX) and are associated with clinical response. |
| Year of Publication |
:
2011
|
| Journal |
:
Arthritis research & therapy
|
| Volume |
:
12
|
| Issue |
:
6
|
| Number of Pages |
:
R211
|
| Date Published |
:
2010
|
| ISSN Number |
:
1478-6354
|
| URL |
:
http://arthritis-research.com/content/12/6/R211
|
| DOI |
:
10.1186/ar3188
|
| Short Title |
:
Association of serum markers with improvement in clinical respon
|
| Download citation |
